Blunted cardiovascular effects of beta-blockers in patients with cirrhosis: Relation to severity?
<h4>Aims</h4>Patients with cirrhosis and portal hypertension are at high risk of developing complications such as variceal hemorrhage, ascites, and cardiac dysfunction, the latter of which is known as cirrhotic cardiomyopathy. Since non-selective beta-blockers (NSBB) may aggravate hemody...
Main Authors: | Puria Nabilou, Karen Vagner Danielsen, Nina Kimer, Jens Dahlgaard Hove, Flemming Bendtsen, Søren Møller |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0270603 |
Similar Items
-
Markers of inflammation predict survival in newly diagnosed cirrhosis: a prospective registry study
by: Thit Mynster Kronborg, et al.
Published: (2023-11-01) -
Nurse-assisted and multidisciplinary outpatient follow-up among patients with decompensated liver cirrhosis: A systematic review
by: Malene Barfod O’Connell, et al.
Published: (2023-01-01) -
Nurse-assisted and multidisciplinary outpatient follow-up among patients with decompensated liver cirrhosis: A systematic review.
by: Malene Barfod O'Connell, et al.
Published: (2023-01-01) -
Cardiac function in patients with early cirrhosis during maximal beta-adrenergic drive: a dobutamine stress study.
by: Aleksander Krag, et al.
Published: (2014-01-01) -
Beta-blockers in patients with liver cirrhosis: Pragmatism or perfection?
by: Tilman Sauerbruch, et al.
Published: (2023-01-01)